UBS noted Thermo Fisher (TMO) was mentioned in a media report as a possible suitor for Pall Corp. (PLL) and feels if the two combine it could create a bio-production "powerhouse." The firm sees a potential deal as accretive and creating unparalleled scale. UBS also said that, based on current valuation, the potential for a deal is barely being priced into Thermo Fisher shares. UBS reiterated its Buy rating and $160 price target on Thermo Fisher shares.
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here